Lebrun, M., Thelen, N., Thiry, M., Riva, L., Ote, I., Condé, C., Vandevenne, P., Di Valentin, E., BONTEMS, S., & Sadzot-Delvaux, C. (2014). Varicella-zoster virus induces the formation of dynamic nuclear capsid aggregates. Virology, 454-455, 311-27. doi:10.1016/j.virol.2014.02.023 |
Riva, L., Thiry, M., Lebrun, M., L'Homme, L., Piette, J., & Sadzot-Delvaux, C. (2014). Deletion of the ORF9p acidic cluster impairs the nuclear egress of Varicella-zoster virus capsids. Journal of Virology. doi:10.1128/JVI.03215-14 |
Bonanni, P., Gershon, A., Gershon, M., Kulcsár, A., Papaevangelou, V., Rentier, B., Sadzot-Delvaux, C., Usonis, V., Vesikari, T., Weil-Olivier, C., de Winter, P., & Wutzler, P. (2013). Primary Versus Secondary Failure After Varicella Vaccination: Implications for Interval Between 2 Doses. Pediatric Infectious Disease Journal, 32 (7), 305-313. doi:10.1097/INF.0b013e31828b7def |
Vandevenne, P., Lebrun, M., El Mjiyad, N., Ote, I., Di Valentin, E., Habraken, Y., Dortu, E., Piette, J., & Sadzot-Delvaux, C. (February 2011). The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3. PLoS ONE, 9 (2). doi:10.1371/journal.pone.0016870 |
Ote, I., Piette, J., & Sadzot-Delvaux, C. (2010). The Varicella-Zoster virus IE4 protein: a conserved member of the herpesviral mRNA export factors family and a potential alternative target in antiherpetic therapies. Biochemical Pharmacology, 80, 1973-1980. doi:10.1016/j.bcp.2010.07.011 |
Vandevenne, P., Sadzot-Delvaux, C., & Piette, J. (2010). Innate immune response and viral interference strategies developed by Human Herpeviruses. Biochemical Pharmacology, 80, 1955-1972. doi:10.1016/j.bcp.2010.07.001 |
Ote, I., Vandevenne, P., Bontems, S., Medina-Palazon, C., Manet, E., Piette, J., Lebrun, M., & Sadzot-Delvaux, C. (18 November 2009). Varicella-Zoster Virus IE4 Protein Interacts with SR Proteins and Exports mRNAs through the TAP/NXF1 Pathway. PLoS ONE, 4 (11), 7882. doi:10.1371/journal.pone.0007882 |
Bonanni, P., Breuer, J., Gershon, A. A., Gershon, M., Hryniewicz, W., Papaevangelou, V., Rentier, B., Rumke, H., Sadzot-Delvaux, C., Senterre, J., Weil-Olivier, C., & Wutzler, P. (28 May 2009). Varicella vaccination in Europe – taking the practical approach. BMC Medicine, 7 (26), 1-38. doi:10.1186/1741-7015-7-26 |
Sadzot-Delvaux, C., Rentier, B., Wutzler, P., Asano, Y., Suga, S., Yoshikawa, T., & Plotkin, S. A. (2008). Varicella vaccination in Japan, South Korea, and Europe. Journal of Infectious Diseases, 197 Suppl 2, 185-90. doi:10.1086/522163 |
Habran, L., El Mjiyad, N., Di Valentin, E., Sadzot-Delvaux, C., Bontems, S., & Piette, J. (October 2007). The varicella-zoster virus immediate-early 63 protein affects chromatin-controlled gene transcription in a cell-type dependent manner. BMC Molecular Biology, 8, 99. doi:10.1186/1471-2199-8-99 |
El Mjiyad, N., Bontems, S., Gloire, G., Horion, J., Vandevenne, P., Dejardin, E., Piette, J., & Sadzot-Delvaux, C. (2007). Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters. Journal of Virology, 81 (23), 13092-104. doi:10.1128/JVI.01378-07 |
Sadzot-Delvaux, C., Di Valentin, E., & Bontems, S. (2006). Le virus de la varicelle et du zona : un alphaherpesvirus pas vraiment comme les autres. Virologie, 10 (3), 219-232. |
Cohen, J. I., Krogmann, T., Bontems, S., Sadzot-Delvaux, C., & Pesnicak, L. (2005). Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for replication in vitro are also critical for efficient establishment of latency. Journal of Virology, 79 (8), 5069-77. doi:10.1128/JVI.79.8.5069-5077.2005 |
Habran, L., Bontems, S., Di Valentin, E., Sadzot-Delvaux, C., & Piette, J. (2005). Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity. Journal of Biological Chemistry, 280 (32), 29135-43. doi:10.1074/jbc.M503312200 |
Nikkels, A., Simonart, T., Kentos, A., Liesnard, C., Sadzot-Delvaux, C., Feremans, W., & Pierard, G. (2003). Atypical recurrent varicella in 4 patients with hemopathies. Journal of the American Academy of Dermatology, 48 (3), 442-7. doi:10.1067/mjd.2003.94 |
Bontems, S., Di Valentin, E., Baudoux, L., Rentier, B., Sadzot-Delvaux, C., & Piette, J. (07 June 2002). Phosphorylation of varicella-zoster virus IE63 protein by casein kinases influences its cellular localization and gene regulation activity. Journal of Biological Chemistry, 277 (23), 21050-21060. doi:10.1074/jbc.M111872200 |
Kennedy, P. G., Grinfeld, E., Bontems, S., & Sadzot-Delvaux, C. (2001). Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia. Virology, 289 (2), 218-23. doi:10.1006/viro.2001.1173 |
Rentier, B., & Sadzot-Delvaux, C. (2000). Le virus de la varicelle et du zona dans le système nerveux : retraite silencieuse ou guérilla permanente ? Virologie, 4 (3), 207-216. |
Sadzot-Delvaux, C., Arvin, A. M., & Rentier, B. (November 1998). Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity. Journal of Infectious Diseases, 178 (Suppl. 1), 43-S47. doi:10.1086/514259 |
Piette, J., Defechereux-Thibaut de Maisières, P., Baudoux-Tebache, L., Sadzot-Delvaux, C., & Rentier, B. (1998). La régulation des cycles infectieux du virus de la varicelle et du zona. M S-Médecine Sciences, 14 (5), 556-565. |
Sadzot-Delvaux, C., Kinchington, P. R., Debrus, S., Rentier, B., & Arvin, A. M. (1997). Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T-lymphocytes. Journal of Immunology, 159 (6), 2802-2806. |
Rentier, B., Piette, J., Baudoux, L., Debrus, S., Defechereux, P., Merville, M.-P., Sadzot-Delvaux, C., & Schoonbroodt, S. (November 1996). Lessons to be learned from varicella-zoster virus. Veterinary Microbiology, 53 (1-2), 55-66. doi:10.1016/S0378-1135(96)01234-5 |
Debrus, S., Sadzot-Delvaux, C., Nikkels, A., Piette, J., & Rentier, B. (1995). Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. Journal of Virology, 69 (5), 3240-3245. doi:10.1128/jvi.69.5.3240-3245.1995 |
Sadzot-Delvaux, C., Thonard, P., Schoonbroodt, S., Piette, J., & Rentier, B. (1995). Varicella-zoster virus induces apoptosis in cell culture. Journal of General Virology, 76 (Pt 11), 2875-2879. doi:10.1099/0022-1317-76-11-2875 |
Snoeck, R., Gerard, M., Sadzot-Delvaux, C., Andrei, G., Balzarini, J., Reymen, D., Piette, J., Rentier, B., Clumeck, N., & De Clercq, E. (1993). Meningoradiculoneuritis due to acyclovir-resistant varicella-zoster virus in a patient with aids. Journal of Infectious Diseases, 168 (5), 1330-1331. doi:10.1093/infdis/168.5.1330 |
Sadzot-Delvaux, C., Marc, P., Lebon, L., Merville, M.-P., Piette, J., & Rentier, B. (1992). Antibodies to varicella-zoster virus modulate antigen distribution but fail to induce viral persistence in vitro. Journal of Virology, 66 (12), 7499-504. doi:10.1128/jvi.66.12.7499-7504.1992 |
Merville-Louis, M. P., Sadzot-Delvaux, C., Delree, P., Piette, J., Moonen, G., & Rentier, B. (1989). Varicella-zoster virus infection of adult rat sensory neurons in vitro. Journal of Virology, 63 (7), 3155-60. doi:10.1128/jvi.63.7.3155-3160.1989 |
Nikkels, A., Debrus, S., Sadzot-Delvaux, C., Rentier, B., & Pierard, G. (1994). Immunohistochemical detection of immediate early and late phase proteins expressed during the varicella-zoster virus cycle. British Journal of Dermatology. Supplement, 131 (44), 64. |
Nikkels, A., Sadzot-Delvaux, C., Cloes, J.-M., Rentier, B., & Pierard, G. (1992). Granulomatous reactions following herpes-zoster contain varicella-zoster glycoprotein GPI. Journal of Investigative Dermatology, 98 (4), 522. |
Lambert, J., Sadzot, C., Lebrun, M., & Thiry, M. (Other coll.). (19 December 2019). Varicella Zoster Virus ORF9p: hijacker of the autophagy pathway? Paper presented at Belvir 2019, Brussels, Belgium. |
Sanchez Gil, J., Collignon, A., Lebrun, M., Rogister, B., Chevigné, A., & Sadzot, C. (15 January 2019). Construction of an oncolytic herpes virus (oHSV) for inducing apoptosis in glioblastoma: proof of concept. Poster session presented at Seminaire Télévie- edition 2019, Gembolux, Belgium. |
Sanchez Gil, J., Lebrun, M., Allegro, A., Chevigné, A., ROGISTER, B., & Sadzot, C. (2019). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted oncolytic herpesvirus. Poster session presented at 12th International Oncolytic Virus conference, Rochester, United States - Minnesota. |
Lambert, J., Lebrun, M., Riva, L., Sanchez Gil, J., Sadzot-Delvaux, C., Andrei, G. (Other coll.), & Snoeck, R. (Other coll.). (29 July 2017). Study of the role of the complex formed by the Varicella Zoster virus ORF9p and the cellular Adaptin Protein-1 in the secondary egress. Poster session presented at IHW 2017, Ghent, Belgium. |
Lebrun, M., riva, L., lambert, J., Rambout, X., Thiry, M., blondeau, C., Twizere, J.-C., Dequiedt, F., & Sadzot-Delvaux, C. (20 May 2016). Role of Varicella Zoster virus ORF9p in the secondary egress : importance of its interaction with the cellular Adaptin Protein-1. Poster session presented at 2015 Colorado Alphaherpesvirus Latency Society Symposium, Vail, United States - Colorado. |
Riva, L., Thiry, M., BONTEMS, S., Joris, A., Piette, J., Lebrun, M., & Sadzot-Delvaux, C. (28 January 2013). ORF9p phosphorylation by ORF47p is crucial for the formation and egress of Varicella-‐ Zoster Virus viral particles. Poster session presented at GIGA-Day, Liège, Belgium. |
Sadzot-Delvaux, C., & Rentier, B. (2001). The role of varicella zoster virus immediate-early proteins in latency and their potential use as components of vaccines. In A. A. Gershon, C. H. Calisher, & A. M. Arvin (Eds.), Immunity to and Prevention of Herpes Zoster (pp. 81-89). Springer. doi:10.1007/978-3-7091-6259-0_9 |
Amorim, C., Andris, F., Arckens, L., Arnould, T., Aron, S., Bakker, J., Balligand, M., Balthazart, J., Baron, F., Beck, B., Beguin, Y., Behets, C., Bellefroid, E., Bertrand, L., Bettendorff, L., Bindels, L., Blankert, B., Blanpain, C., Bondue, A., & Wittamer, V. (2017). L’expérimentation animale reste indispensable (OPINION). La Libre Belgique. |